BioSpace News Archive

Neurolief, a medical neurotechnology innovator, today announced new data released at the 65th Annual Scientific Meeting hosted by the American Headache Society (June 15-18, 2023, Austin, TX).

Novo Nordisk announced today that it is taking multiple actions to protect US patients from the unlawful marketing and sales of non-FDA approved counterfeit and compounded semaglutide products claiming to contain semaglutide, while reinforcing the responsible use of Novo Nordisk’s FDA-approved medicines.

Evotec SE announced that its shareholders approved all proposals the Company’s Management put to vote at the Company’s virtual Annual General Meeting 2023 with the required majority.

Isotopia plans to establish its US isotope manufacturing operations over the next 13 months and anticipates providing GMP-grade Lu-177 n.c.a. to its key customers in 2024.

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Company has received €1.5 million in non-dilutive funding from Bpifrance - Direction Régionale de Nantes.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

IRLAB Therapeutics AB held its Annual General Meeting at Wallenbergs Konferenscentrum, Medicinaregatan 20 A in Gothenburg, Sweden.

The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton).

MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of people with brain disorders, announced the appointment of Kris Hanson as the company’s General Counsel.

Allarity Therapeutics, Inc. announced that the special meeting of stockholders on June 20, 2023 was adjourned, without conducting any business, until June 23, 2023 to provide additional time for the Company to obtain approval of the proposals as described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on June 6, 2023.